256 related articles for article (PubMed ID: 14762163)
1. Preferential oxidation of the second phosphatase domain of receptor-like PTP-alpha revealed by an antibody against oxidized protein tyrosine phosphatases.
Persson C; Sjöblom T; Groen A; Kappert K; Engström U; Hellman U; Heldin CH; den Hertog J; Ostman A
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):1886-91. PubMed ID: 14762163
[TBL] [Abstract][Full Text] [Related]
2. Oxidation sensitivity of the catalytic cysteine of the protein-tyrosine phosphatases SHP-1 and SHP-2.
Weibrecht I; Böhmer SA; Dagnell M; Kappert K; Ostman A; Böhmer FD
Free Radic Biol Med; 2007 Jul; 43(1):100-10. PubMed ID: 17561098
[TBL] [Abstract][Full Text] [Related]
3. Reversible oxidation of the membrane distal domain of receptor PTPalpha is mediated by a cyclic sulfenamide.
Yang J; Groen A; Lemeer S; Jans A; Slijper M; Roe SM; den Hertog J; Barford D
Biochemistry; 2007 Jan; 46(3):709-19. PubMed ID: 17223692
[TBL] [Abstract][Full Text] [Related]
4. An antibody-based method for monitoring in vivo oxidation of protein tyrosine phosphatases.
Persson C; Kappert K; Engström U; Ostman A; Sjöblom T
Methods; 2005 Jan; 35(1):37-43. PubMed ID: 15588984
[TBL] [Abstract][Full Text] [Related]
5. Differential oxidation of protein-tyrosine phosphatases.
Groen A; Lemeer S; van der Wijk T; Overvoorde J; Heck AJ; Ostman A; Barford D; Slijper M; den Hertog J
J Biol Chem; 2005 Mar; 280(11):10298-304. PubMed ID: 15623519
[TBL] [Abstract][Full Text] [Related]
6. A modified cysteinyl-labeling assay reveals reversible oxidation of protein tyrosine phosphatases in angiomyolipoma cells.
Boivin B; Zhang S; Arbiser JL; Zhang ZY; Tonks NK
Proc Natl Acad Sci U S A; 2008 Jul; 105(29):9959-64. PubMed ID: 18632564
[TBL] [Abstract][Full Text] [Related]
7. Two vicinal cysteines confer a peculiar redox regulation to low molecular weight protein tyrosine phosphatase in response to platelet-derived growth factor receptor stimulation.
Chiarugi P; Fiaschi T; Taddei ML; Talini D; Giannoni E; Raugei G; Ramponi G
J Biol Chem; 2001 Sep; 276(36):33478-87. PubMed ID: 11429404
[TBL] [Abstract][Full Text] [Related]
8. Intra- and intermolecular interactions between intracellular domains of receptor protein-tyrosine phosphatases.
Blanchetot C; Tertoolen LG; Overvoorde J; den Hertog J
J Biol Chem; 2002 Dec; 277(49):47263-9. PubMed ID: 12376545
[TBL] [Abstract][Full Text] [Related]
9. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation.
Denu JM; Tanner KG
Biochemistry; 1998 Apr; 37(16):5633-42. PubMed ID: 9548949
[TBL] [Abstract][Full Text] [Related]
10. Restoration of potent protein-tyrosine phosphatase activity into the membrane-distal domain of receptor protein-tyrosine phosphatase alpha.
Buist A; Zhang YL; Keng YF; Wu L; Zhang ZY; den Hertog J
Biochemistry; 1999 Jan; 38(3):914-22. PubMed ID: 9893986
[TBL] [Abstract][Full Text] [Related]
11. Development of a modified in-gel assay to identify protein tyrosine phosphatases that are oxidized and inactivated in vivo.
Meng TC; Hsu SF; Tonks NK
Methods; 2005 Jan; 35(1):28-36. PubMed ID: 15588983
[TBL] [Abstract][Full Text] [Related]
12. Regulation of receptor protein-tyrosine phosphatase alpha by oxidative stress.
Blanchetot C; Tertoolen LG; den Hertog J
EMBO J; 2002 Feb; 21(4):493-503. PubMed ID: 11847098
[TBL] [Abstract][Full Text] [Related]
13. The myeloperoxidase-derived oxidant hypothiocyanous acid inhibits protein tyrosine phosphatases via oxidation of key cysteine residues.
Cook NL; Moeke CH; Fantoni LI; Pattison DI; Davies MJ
Free Radic Biol Med; 2016 Jan; 90():195-205. PubMed ID: 26616646
[TBL] [Abstract][Full Text] [Related]
14. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo.
Meng TC; Fukada T; Tonks NK
Mol Cell; 2002 Feb; 9(2):387-99. PubMed ID: 11864611
[TBL] [Abstract][Full Text] [Related]
15. Redox regulation of SH2-domain-containing protein tyrosine phosphatases by two backdoor cysteines.
Chen CY; Willard D; Rudolph J
Biochemistry; 2009 Feb; 48(6):1399-409. PubMed ID: 19166311
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of PTP-SL/PTPBR7 catalytic domain: implications for MAP kinase regulation.
Szedlacsek SE; Aricescu AR; Fulga TA; Renault L; Scheidig AJ
J Mol Biol; 2001 Aug; 311(3):557-68. PubMed ID: 11493009
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia followed by re-oxygenation induces oxidation of tyrosine phosphatases.
Sandin A; Dagnell M; Gonon A; Pernow J; Stangl V; Aspenström P; Kappert K; Ostman A
Cell Signal; 2011 May; 23(5):820-6. PubMed ID: 21241797
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of protein-tyrosine phosphatases activates an immune receptor in the absence of its translocation into lipid rafts.
Heneberg P; Dráberová L; Bambousková M; Pompach P; Dráber P
J Biol Chem; 2010 Apr; 285(17):12787-802. PubMed ID: 20157115
[TBL] [Abstract][Full Text] [Related]
19. Effects of SOV-induced phosphatase inhibition and expression of protein tyrosine phosphatases in rat corneal endothelial cells.
Chen WL; Harris DL; Joyce NC
Exp Eye Res; 2005 Nov; 81(5):570-80. PubMed ID: 15950220
[TBL] [Abstract][Full Text] [Related]
20. Antioxidants relieve phosphatase inhibition and reduce PDGF signaling in cultured VSMCs and in restenosis.
Kappert K; Sparwel J; Sandin A; Seiler A; Siebolts U; Leppänen O; Rosenkranz S; Ostman A
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2644-51. PubMed ID: 16990553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
